Search results for Olendalizumab
Olendalizumab Biosimilar – Anti-C5 mAb – Research Grade, ProteoGenix, PX-TA1406
Description of Olendalizumab Biosimilar - Anti-C5 mAb - Research Grade General information on Anti-C5[Homo sapiens] (Olendalizumab) Monoclonal Antibody Olendalizumab has been investigated for the treatment of Graft-versus-host disease, Antiphospholipid syndrome.
Host
Reactivity
Applications
Conjugation
Olendalizumab, Abbexa, abx831364
Olendalizumab is a monoclonal antibody biosimilar expressed in CHO cells, targeting C5, for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications.
Host
Human
Reactivity
Human
Applications
ELISA, WB
Conjugation
Unconjugated
Olendalizumab Biosimilar - Research Grade, ichor.bio, ICH5727
Host
CHO Cells
Reactivity
Human
Applications
Conjugation
Research Grade Olendalizumab (HF687036), abinScience, HF687036
Host
Humanized
Reactivity
Human
Applications
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Conjugation
Please provide the required information below so that we can quickly source your products.